Abstract
Anesthetized Sprague-Dawley rats fitted with intracerebroventricular (i.c.v.) cannulas were infused with one of the aminopeptidase inhibitors, amastatin or bestatin, over a 5-min period. After infusion, 1–2 × 10 6 cpm of [ 125I]angiotensin II([ 125I]AII) or [ 125I]angiotensin III([ 125AIII) was injected through the same cannula. The rats were subsequently killed 60 s later by focused microwave irradiation which instantaneously terminated further [ 125I]angiotensin metabolism. HPLC analysis of the extracted [ 125I]angiotensin and metabolic products allowed for the calculation of t 1 2 s of disappearance for the parent peptides. Both inhibitors effectively lengthened the half-lives of [ 125I]AII and [ 125I]AIII. Bestatin, which is considered a selective aminopeptidase B blocker, had a more pronounced effect on [ 125I]AIII metabolism, while amastatin, a selective aminopeptidase A inhibitor, was better at slowing [ 125I]AII degradation. The results indicate that amastatin and bestatin are very effective blockers of the cerebroventricular metabolism of angiotensins but are only marginally selective with regard to AII and AIII.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have